Premium
Use of direct oral anticoagulants in thromboembolic disease
Author(s) -
Wilson Matthew R,
Docherty Kieran F,
Gardner Roy S
Publication year - 2016
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1487
Subject(s) - medicine , thromboembolic disease , warfarin , intensive care medicine , disease , atrial fibrillation , thrombosis
Direct oral anticoagulants (DOACs) offer several advantages over warfarin in the management of thromboembolic disease. This article discusses their indications, mode of action, side‐effects and interactions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom